ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial of Observed Long-acting, Anti-HIV Treatment With a Monoclonal CCR5 Antibody (PRO 140) as an Adjunct to a New, Optimized, Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01272258
Recruitment Status : Withdrawn (Lack of enrollment)
First Posted : January 7, 2011
Last Update Posted : February 2, 2017
Sponsor:
Information provided by (Responsible Party):
CytoDyn, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : January 2017
  Estimated Study Completion Date : February 2017